Incyte (INCY) EBITDA (2010 - 2026)

Incyte's EBITDA history runs 17 years deep, the most recent figure standing at $301.1 million for Q1 2026.

• Quarterly EBITDA rose 46.77% year-over-year to $301.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 822.38% YoY) and the FY2025 annual result came in at $1.5 billion, up 2368.56% from the prior year.
• EBITDA was $301.1 million for Q1 2026 at Incyte, down from $335.9 million in the prior quarter.
• Across five years, EBITDA topped out at $530.3 million in Q2 2025 and bottomed at -$478.1 million in Q2 2024.
• A 5-year average of $181.0 million and a median of $193.8 million in 2023 frame the typical range for EBITDA.
• Peak annual rise in EBITDA reached 271.01% in 2024, while the deepest fall reached 346.74% in 2024.
• Incyte's EBITDA stood at $70.1 million in 2022, then jumped by 167.17% to $187.3 million in 2023, then jumped by 61.0% to $301.5 million in 2024, then grew by 11.39% to $335.9 million in 2025, then dropped by 10.34% to $301.1 million in 2026.
• Business Quant data shows INCY's EBITDA at $301.1 million in Q1 2026, $335.9 million in Q4 2025, and $443.5 million in Q3 2025.